Page last updated: 2024-08-16

delavirdine and thymidine

delavirdine has been researched along with thymidine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balzarini, J; Camarasa, MJ; De Clercq, E; Karlsson, A; Pérez-Pérez, MJ; San-Félix, A; Vélazquez, S	1
Campiani, G; Catalanotti, B; Fattorusso, C; Maga, G; Morelli, E; Nacci, V; Novellino, E; Ramunno, A	1

Reviews

1 review(s) available for delavirdine and thymidine

Article	Year
Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives. Current pharmaceutical design, 2002, Volume: 8, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzodiazepinones; Benzoxazines; Cyclopropanes; Delavirdine; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Viral; Drug Therapy, Combination; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Structure; Nevirapine; Nucleosides; Oxazines; Reverse Transcriptase Inhibitors; Spiro Compounds; Thymidine; Uridine	2002

Article

Year

Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives.

Current pharmaceutical design, 2002, Volume: 8, Issue:8

Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzodiazepinones; Benzoxazines; Cyclopropanes; Delavirdine; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Viral; Drug Therapy, Combination; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Structure; Nevirapine; Nucleosides; Oxazines; Reverse Transcriptase Inhibitors; Spiro Compounds; Thymidine; Uridine

2002

Other Studies

1 other study(ies) available for delavirdine and thymidine

Article	Year
Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives). Proceedings of the National Academy of Sciences of the United States of America, 1995, Jun-06, Volume: 92, Issue:12 Topics: Antiviral Agents; Base Sequence; Carboxin; Cell Line; Delavirdine; DNA Primers; Drug Antagonism; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Molecular Sequence Data; Mutation; Piperazines; Reverse Transcriptase Inhibitors; Spiro Compounds; Thymidine	1995

Article

Year

Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives).

Proceedings of the National Academy of Sciences of the United States of America, 1995, Jun-06, Volume: 92, Issue:12

Topics: Antiviral Agents; Base Sequence; Carboxin; Cell Line; Delavirdine; DNA Primers; Drug Antagonism; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Molecular Sequence Data; Mutation; Piperazines; Reverse Transcriptase Inhibitors; Spiro Compounds; Thymidine

1995